Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
doxorubicin (Doxil) (1 trial)
paclitaxel (taxol) (1 trial)
Carcinoma, Ovarian Epithelial (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Hypersensitivity (Phase 2)
Ovarian Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)